145 related articles for article (PubMed ID: 37030135)
1. Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method.
Sato Y; Elbadawy M; Suzuki K; Tsunedomi R; Nagano H; Ishihara Y; Yamamoto H; Azakami D; Uchide T; Nabeta R; Fukushima R; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Usui T; Sasaki K
Biomed Pharmacother; 2023 Jun; 162():114651. PubMed ID: 37030135
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
[TBL] [Abstract][Full Text] [Related]
3. Establishing mesothelioma patient-derived organoid models from malignant pleural effusions.
Hocking AJ; Mortimer LA; Farrall AL; Russell PA; Klebe S
Lung Cancer; 2024 May; 191():107542. PubMed ID: 38555809
[TBL] [Abstract][Full Text] [Related]
4. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
5. Matrigel-based organoid culture of malignant mesothelioma reproduces cisplatin sensitivity through CTR1.
Ito F; Kato K; Yanatori I; Maeda Y; Murohara T; Toyokuni S
BMC Cancer; 2023 May; 23(1):487. PubMed ID: 37254056
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells.
Usui T; Sakurai M; Nishikawa S; Umata K; Nemoto Y; Haraguchi T; Itamoto K; Mizuno T; Noguchi S; Mori T; Iwai S; Nakagawa T; Yamawaki H; Ohama T; Sato K
Cancer Sci; 2017 Dec; 108(12):2383-2392. PubMed ID: 29024204
[TBL] [Abstract][Full Text] [Related]
7. Derivation of a new model of lung adenocarcinoma using canine lung cancer organoids for translational research in pulmonary medicine.
Shiota Sato Y; Elbadawy M; Suzuki K; Tsunedomi R; Nagano H; Ishihara Y; Yamamoto H; Azakami D; Uchide T; Fukushima R; Tanaka R; Yoshida T; Mori T; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Aboubakr M; El-Asrag ME; Usui T; Sasaki K
Biomed Pharmacother; 2023 Sep; 165():115079. PubMed ID: 37413906
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a direct 2.5D organoid culture model using companion animal cancer tissues.
Abugomaa A; Elbadawy M; Yamamoto H; Ayame H; Ishihara Y; Sato Y; Yamawaki H; Kaneda M; Usui T; Sasaki K
Biomed Pharmacother; 2022 Oct; 154():113597. PubMed ID: 36030590
[TBL] [Abstract][Full Text] [Related]
9. Canine Intestinal Organoids in a Dual-Chamber Permeable Support System.
Gabriel V; Zdyrski C; Sahoo DK; Dao K; Bourgois-Mochel A; Atherly T; Martinez MN; Volpe DA; Kopper J; Allenspach K; Mochel JP
J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311824
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an experimental model of normal dog bladder organoid using a three-dimensional culture method.
Elbadawy M; Fujisaka K; Yamamoto H; Tsunedomi R; Nagano H; Ayame H; Ishihara Y; Mori T; Azakami D; Uchide T; Fukushima R; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Omatsu T; Mizutani T; Usui T; Sasaki K
Biomed Pharmacother; 2022 Jul; 151():113105. PubMed ID: 35605292
[TBL] [Abstract][Full Text] [Related]
11. Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma.
Chen H; Gotimer K; De Souza C; Tepper CG; Karnezis AN; Leiserowitz GS; Chien J; Smith LH
Gynecol Oncol; 2020 Jun; 157(3):783-792. PubMed ID: 32253045
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
[TBL] [Abstract][Full Text] [Related]
13. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma.
Fang X; Shu L; Chen T; Zhao X; Yang L; Dou T; Yang L; Li X; Feng M
Mol Cancer; 2024 Jan; 23(1):12. PubMed ID: 38200517
[TBL] [Abstract][Full Text] [Related]
14. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
15. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.
Kulkarni NS; Vaidya B; Parvathaneni V; Bhanja D; Gupta V
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878257
[TBL] [Abstract][Full Text] [Related]
18. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
19. Genetic characterization of a novel organoid from human malignant giant-cell tumor.
Suzuki R; Wakamatsu T; Yoshida K; Matsuoka Y; Takami H; Nakai S; Tamiya H; Kakunaga S; Yagi T; Yoshida KI; Imura Y; Yui Y; Sasagawa S; Takenaka S
J Bone Oncol; 2023 Aug; 41():100486. PubMed ID: 37260767
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
